Analyst Research

Report Title Price
Provider: Edison Investment Research
$10.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$460.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Medicrea International SA Receives FDA Approval for PASS LP Systems


Thursday, 21 Mar 2013 03:30am EDT 

Medicrea International SA announced the FDA approval of the PASS LP system for the treatment of adolescent idiopathic scoliosis. The PASS LP is the lowest profile pedicle screw spinal fusion system available on the market and has been designed to address complex spinal pathologies making it specifically adapted to pediatric indications. The PASS LP thoraco-lumbar fixation system allows connection of the rod at a distance from the spine and performs a three-dimensional (3D) correction of the deformity through gentle and progressive stress distribution on all anchorages using the ST2R technique (Simultaneous Translation on 2 Rods). Through its derotation connectors & technique, the PASS LP offers a way to achieve correction of the deformity in all planes. Derotation in the coronal plane is obtained with no risk of screw ploughing or pull out while preserving sagittal balance, essential in the treatment of adolescent idiopathic scoliosis. 

Company Quote

8.24
0.1 +1.23%
11:28am EDT